Research map: SGLT2 Inhibitor Use in Type 2 Diabetes in England: A Population‐Based Cross‐Sectional Study of Uptake of NICE Guidance

Back to the article

Papers in this map

  1. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes · Stephen D. Wiviott · 2018 · 6475 citations · Cited by this paper
  2. Economic Impact of Multidisciplinary Pre‐operative Diabetes Care Versus Usual Care in Adults Undergoing Elective Non‐cardiac Surgery in Australia: A Trial‐Based Analysis · 2026 · Related
  3. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy · Vlado Perkovic · 2019 · 6222 citations · Cited by this paper
  4. Feasibility of Decentralised Response‐Guided Albuminuria Monitoring to Optimise Empagliflozin and Finerenone Therapy in Type 2 Diabetes and Chronic Kidney Disease · 2026 · Related
  5. Data Resource Profile: Clinical Practice Research Datalink (CPRD) · Emily L. Herrett · 2015 · 2781 citations · Cited by this paper
  6. Metformin Ameliorates Diabetes‐Associated Cognitive Dysfunction via p53/Parkin‐Mediated Mitophagy · 2026 · Related
  7. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association · Chiadi E. Ndumele · 2023 · 2076 citations · Cited by this paper
  8. Trends and Prevalence of Undiagnosed Dysglycemia Among Reproductive‐Age Women in the United States · 2026 · Related
  9. Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum · Achim Wolf · 2019 · 945 citations · Cited by this paper
  10. Beyond Glycaemia: Fear of Hypoglycaemia, Cognition and Functional Mobility After Advanced Hybrid Closed‐Loop Therapy in Older Adults With Type 1 Diabetes: A Prespecified Secondary Analysis of a Randomised, Single‐Centre Study · 2026 · Related
  11. Measuring Multiple Deprivation at the Small-Area Level · Michael Noble · 2006 · 515 citations · Cited by this paper
  12. Diagnostic Yield of Structured Cushing Syndrome Evaluation in Treatment‐Resistant Non‐Diabetic Obesity: A Retrospective Pilot Study · 2026 · Related
  13. Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study · Emily L. Herrett · 2013 · 384 citations · Cited by this paper
  14. Exercise Snacks Are Feasible to Perform in the Real World and Improve Physical Capacity for Adults Living With Non‐Insulin Treated Type 2 Diabetes: A Randomised Trial · 2026 · Related
  15. Completeness, agreement, and representativeness of ethnicity recording in the United Kingdom’s Clinical Practice Research Datalink (CPRD) and linked Hospital Episode Statistics (HES) · Suhail Ismail Shiekh · 2023 · 132 citations · Cited by this paper
  16. Real‐World Effectiveness and Safety of Finerenone in People With Type 2 Diabetes and Chronic Kidney Disease: A Spanish Multicentre Retrospective Observational Study ( MEDFINE ‐ RWD ) · 2026 · Related
  17. Variations in comorbidity burden in people with type 2 diabetes over disease duration: A population-based analysis of real world evidence · Jonathan Pearson‐Stuttard · 2022 · 92 citations · Cited by this paper
  18. Sodium Butyrate Attenuates Renal Fibrosis by Regulating Glycolysis and Histone H4K12 Lactylation in Diabetic Kidney Disease · 2026 · Related
  19. Prescribing in Type 2 Diabetes Patients With and Without Cardiovascular Disease History: A Descriptive Analysis in the UK CPRD · Ruth E. Farmer · 2021 · 61 citations · Cited by this paper
  20. Methodological and Conceptual Concerns Regarding the 24‐h Glycaemia/C‐Peptide Ratio as a Novel Insulin Sensitivity Index · 2026 · Related
  21. Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study · Anna Forbes · 2024 · 53 citations · Cited by this paper
  22. Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis · Helen Jane Curtis · 2018 · 25 citations · Cited by this paper
  23. Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse events · Heather Wightman · 2025 · 14 citations · Cited by this paper
  24. Uptake of SGLT2i and Outcomes in Patients with Diabetes and Heart Failure: A Population-Based Cohort and a Specialized Clinic Cohort · Luke R. Gagnon · 2024 · 11 citations · Cited by this paper
  25. Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset · Hannah Wallace · 2025 · 10 citations · Cited by this paper
  26. Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based study · Jialing Lin · 2025 · 8 citations · Cited by this paper
  27. Untitled · Cited by this paper

Source: OpenAlex (CC0)